(Q37412005)

English

Treatment of scleroderma-interstitial lung disease with cyclophosphamide is associated with less progressive fibrosis on serial thoracic high-resolution CT scan than placebo: findings from the scleroderma lung study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Treatment of scleroderma-interstitial lung disease with cyclophosphamide is associated with less progressive fibrosis on serial thoracic high-resolution CT scan than placebo: findings from the scleroderma lung study (English)

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

0 references

1 reference

based on heuristic

inferred from title

Robert Elashoff

2

object named as

Robert Elashoff

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

author name string

Jonathan Goldin

1

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Hyun J Kim

3

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Xaiohong Yan

4

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

David Lynch

5

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Diane Strollo

6

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Michael D Roth

7

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Philip Clements

8

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Daniel E Furst

9

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Dinesh Khanna

10

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Srainnapha Vasunilashorn

11

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Gang Li

12

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Donald P Tashkin

13

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

language of work or name

0 references

publication date

1 November 2009

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

136

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

5

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

1333-1340

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

High-resolution computed tomography and scleroderma lung disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773360

6 September 2017

High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773360

6 September 2017

Classification of parenchymal abnormality in scleroderma lung using a novel approach to denoise images collected via a multicenter study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773360

6 September 2017

Therapeutic strategy combining intravenous cyclophosphamide followed by oral azathioprine to treat worsening interstitial lung disease associated with systemic sclerosis: a retrospective multicenter open-label study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773360

6 September 2017

Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773360

6 September 2017

Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773360

6 September 2017

A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773360

6 September 2017

Cyclophosphamide versus placebo in scleroderma lung disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773360

6 September 2017

Evaluation and management of alveolitis and interstitial lung disease in scleroderma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773360

6 September 2017

Non-specific interstitial pneumonia as pulmonary involvement of systemic sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773360

6 September 2017

Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773360

6 September 2017

Interstitial lung disease in systemic sclerosis: a simple staging system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773360

2 September 2018

CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773360

2 September 2018

Systemic sclerosis and interstitial lung disease: a pilot study using pulse intravenous methylprednisolone and cyclophosphamide to assess the effect on high resolution computed tomography scan and lung function.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773360

2 September 2018

The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773360

2 September 2018

Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773360

2 September 2018

Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773360

2 September 2018

Cyclophosphamide with low or high dose prednisolone for systemic sclerosis lung disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773360

2 September 2018

Serial CT in fibrosing alveolitis: prognostic significance of the initial pattern.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773360

2 September 2018

Severe restrictive lung disease in systemic sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773360

2 September 2018

Intravenous cyclophosphamide pulse therapy for the treatment of lung disease associated with scleroderma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19892673

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Severe organ involvement in systemic sclerosis with diffuse scleroderma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19892673

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes

1 reference

https://pubmed.ncbi.nlm.nih.gov/19892673

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation and management of scleroderma lung disease using bronchoalveolar lavage

1 reference

https://pubmed.ncbi.nlm.nih.gov/19892673

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. The BAL Cooperative Group Steering Committee

1 reference

https://pubmed.ncbi.nlm.nih.gov/19892673

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pulmonary involvement in progressive systemic sclerosis: sequential evaluation with CT, pulmonary function tests, and bronchoalveolar lavage

1 reference

https://pubmed.ncbi.nlm.nih.gov/19892673

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19892673

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide for scleroderma lung disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19892673

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19892673

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1378/CHEST.09-0108

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37412005&oldid=1704976252"